*The products are for research or manufacturing use only, not for use in human therapeutic or diagnostic applications.

Importance

Modifications on lysine residues, with formation of carboxylmethyl-lysine (CML), malondialdehyde (MDA) and hexitol-lysine are advanced glycation end-products (AGE), and the coupling with reactive aldehyde compounds, such as 4-hydroxynonenal (4-HNE) may appear from lipid oxidation (Guichardant et al., 1998). These modifications feature the oxidative byproducts which react with NH2 groups and form Schiff-base adducts (Mark et al., 1996).

LDL treated with HNE or oxidatively modified by Cu++ or by cultured endothelial cells give rise to Michael addition-type HNE adducts that are recognized by HNE-specific antibodies.

Guichardant M, Taibi-Tronche P, Fay LB, Lagarde M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med. 1998 Dec;25(9):1049-56.

Mark S. Bolgar, Chao-Yuh Yang, and Simon J. Gaskell, First Direct Evidence for Lipid/Protein Conjugation in Oxidized Human Low Density Lipoprotein (LDL), JBC, 271: 27999-28001 (1996).

Citations

Academy Bio-Medical Company，Inc.专营人类脂蛋白，载脂蛋白和多克隆抗体。以可承受的价格制造和提供高质量的抗体。

自1995年以来，该公司一直以研究试剂为心血管和动脉粥样硬化研究界提供支持。我们自豪地提供致力于脂蛋白，载脂蛋白及其氧化修饰产品领域研究的抗体和试剂。我们的抗体产品得到我们技术服务专家的全面支持。